SF 1.1% Gel 1.1% Sodium Fluoride - Brush-On Gel

Manufacturer
Cypress Pharmaceutical, Inc. | Faria Limited dba Sheffield Pharmaceuticals
Effective date
2016-07-06
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 20:22:30

Label at a glance#

ProductSF
Active ingredientSODIUM FLUORIDE
Label structure18 sections

Indications and uses

A dental caries preventive, for once daily self-applied topical use.  It is well established that 1.1% sodium fluoride is safe and extraordinarily effective as a caries preventive when applied frequently with mouthpiece applicators. 1-4 SF 1.1% Brush-On Gel in a squeeze-tube is easily applied onto a toothbrush as well as a mouthpiece tray.  This prescription dental gel should be used once daily following use of a ...

Dosage and administration

Follow these instructions unless otherwise instructed by your dental professional: 1. After brushing thoroughly with toothpaste, rinse as usual.  Adults and pediatric patients 6 years of age or older, apply a thin ribbon of gel to the teeth with a toothbrush or mouth trays once daily for at least one minute, preferably at bedtime.  2. After use, adults expectorate gel.  For the best results, do not eat, drink, or ...

Storage and handling

Store at Controlled Room Temperature, 20 o -25 o C  (68 o -77 o F). Rx only

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

Self-topical neutral fluoride gel containing 1.1% (w/v) sodium fluoride for use as a dental caries preventive in pediatric patients and adults.  This prescription product is not a dentifrice.

Active Ingredient:
Sodium Fluoride, USP 1.1% (w/v).

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Purified Water, Sorbitol, Hydroxyethylcellulose, Flavor, Poloxamer 407, Sodium Saccharin, Methylparaben, Propylparaben, FD&C Blue No. 1.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Frequent topical applications to the teeth with preparations having a relatively high fluoride content increase tooth resistance to acid dissolution and enhance penetration of the fluoride ion into tooth enamel.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

A dental caries preventive, for once daily self-applied topical use.  It is well established that 1.1% sodium fluoride is safe and extraordinarily effective as a caries preventive when applied frequently with mouthpiece applicators.1-4 SF 1.1% Brush-On Gel in a squeeze-tube is easily applied onto a toothbrush as well as a mouthpiece tray.  This prescription dental gel should be used once daily following use of a regular toothpaste unless otherwise instructed by your dental professional.  May be used whether or not drinking water is fluoridated since topical fluoride cannot produce fluorosis. (See WARNINGS for exception.)

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Do not use in pediatric patients under age 6 years unless recommended by a dentist or physician.

WARNINGS

WARNINGS SECTION

Prolonged daily ingestion may result in various degrees of dental fluorosis in pediatric patients under 6 years, especially if the water fluoridation exceeds 0.6 ppm, since younger pediatric patients frequently cannot perform the brushing process without significant swallowing.  Use in pediatric patients under age 6 years requires special supervision to prevent repeated swallowing of gel which could cause dental fluorosis.  Read directions carefully before using. If using a mouthpiece application, prolonged exposure (longer than 1 minute) may result in oral irritation, such as burning. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. IN CASE OF ACCIDENTAL OVERDOSAGE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY.

PRECAUTIONS

PRECAUTIONS SECTION

Not for systemic treatment.  DO NOT SWALLOW.

Carcinogenesis, Mutagenesis, Impairment of Fertility

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

In a study conducted in rodents, no carcinogenesis was found in male and female mice and female rats treated with fluoride at dose levels ranging from 4.1 to 9.1 mg/kg of body weight.  Equivocal evidence of carcinogenesis was reported in male rats treated with 2.5 and 4.1 mg/kg of body weight. In a second study, no carcinogenesis was observed in rats, males or females, treated with fluoride up to 11.3 mg/kg of body weight.  Epidemiological data provide no credible evidence for an association between fluoride, either naturally occurring or added to drinking water, and risk of human cancer. 

Fluoride ion is not mutagenic in standard bacterial systems.  It has been shown that fluoride ion has potential to induce chromosome aberrations in cultured human and rodent cells at doses much higher than those to which humans are exposed.  In vivo data are conflicting.  Some studies report chromosome damage in rodents, while other studies using similar protocols report negative results. 

Potential adverse reproductive effects of fluoride exposure in humans has not been adequately evaluated.  Adverse effects on reproduction were reported for rats, mice, fox, and cattle exposed to 100 ppm or greater concentrations of fluoride in their diet or drinking water.  Other studies conducted in rats demonstrated that lower concentrations of fluoride (5 mg/kg of body weight) did not result in impaired fertility and reproductive capabilities. 

Pregnancy

PREGNANCY SECTION

Pregnancy Category B.  It has been shown that fluoride crosses the placenta of rats, but only 0.01% of the amount administered is incorporated in fetal tissue.  Animal studies (rats, mice, rabbits) have shown that fluoride is not a teratogen.  Maternal exposure to 12.2 mg fluoride/kg of body weight (rats) or 13.1 mg/kg of body weight (rabbits) did not affect the litter size or fetal weight and did not increase the frequency of skeletal or visceral malformations.  Epidemiological studies conducted in areas with high levels of naturally fluoridated water showed no increase in birth defects.  Heavy exposure to fluoride in utero development may result in skeletal fluorosis which becomes evident in childhood.

Nursing Mothers

NURSING MOTHERS SECTION

It is not known if fluoride is excreted in human milk.  However, many drugs are excreted in milk, and caution should be exercised when products containing fluoride are administered to a nursing woman.  Reduced milk production was reported in farm-raised fox when animals were fed a diet containing a high concentration of fluoride (98-137 mg/kg of body weight).  No adverse effects on parturition, lactation, or offspring were seen in rats administered fluoride up to 5 mg/kg of body weight. 

Pediatric Use

PEDIATRIC USE SECTION

The use of SF 1.1% Brush-On Gel in pediatric age groups 6 to 16 years as a caries preventive is supported by pioneering clinical studies with 1.1% sodium fluoride gels in mouth trays in students age 11-14 years conducted by Englander, et al.2,3,4.  Safety and effectiveness in pediatric patients below the age of 6 years have not been established.  Please refer to the CONTRAINDICATIONS and WARNINGS sections.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Allergic reactions and other idiosyncrasies have been rarely reported.

OVERDOSAGE

OVERDOSAGE SECTION

Accidental ingestion of large amounts of fluoride may result in acute burning in the mouth and sore tongue.  Nausea, vomiting, and diarrhea may occur soon after ingestion (within 30 minutes) and are accompanied by salivation, hematemesis, and epigastric cramping and abdominal pain.  These symptoms may persist for 24 hours.  If less than 5 mg fluoride/kg body weight (i.e., less than 2.3 mg fluoride/lb body weight) have been ingested, give calcium (e.g., milk) orally to relieve gastrointestinal symptoms and observe for a few hours.  If more than 5 mg fluoride/kg body weight (i.e., more than 2.3 mg fluoride/lb body weight) have been ingested, induce emesis, give orally soluble calcium (e.g., milk, 5% calcium gluconate or calcium lactate solution) and immediately seek medical assistance.  For accidental ingestion of more than 15 mg fluoride/kg of body weight (i.e., more than 6.9 mg fluoride/lb body weight), induce vomiting and admit immediately to a hospital facility.

A treatment dose (a thin ribbon) of SF 1.1% Brush-On Gel contains 2 mg flouride. A 2 oz. tube contains 266 mg fluoride.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Follow these instructions unless otherwise instructed by your dental professional: 1. After brushing thoroughly with toothpaste, rinse as usual.  Adults and pediatric patients 6 years of age or older, apply a thin ribbon of gel to the teeth with a toothbrush or mouth trays once daily for at least one minute, preferably at bedtime.  2. After use, adults expectorate gel.  For the best results, do not eat, drink, or rinse for 30 minutes.  Pediatric patients, age 6-16, expectorate gel after use and rinse mouth thoroughly.

HOW SUPPLIED

HOW SUPPLIED SECTION

2 oz. (56g) net wt. plastic tube.

Flavor: Fresh Mint

NDC 60258-151-01

STORAGE

STORAGE AND HANDLING SECTION

Store at Controlled Room Temperature, 20o-25oC  (68o-77oF).

Rx only

REFERENCES

REFERENCES SECTION

1. American Dental Association, Council on Dental Therapeutics, Fluoride compounds, In: Accepted Dental Therapeutics, Ed. 40, Chicago, ADA, 405-407 (1984).  2.  H.R. Englander et al., Clinical Anticaries Effect of Repeated Topical Sodium Fluoride Applications by Mouthpieces, JADA, 75, 638-644 (1967).  3.  H.R. Englander et al., Residual Anticaries Effect of Repeated Topical Sodium Fluoride Applications by Mouthpieces, JADA, 78, 783-787 (1969).  4.  H.R. Englander et al., Incremental Rates of Dental Caries After Repeated Topical Sodium Fluoride Applications in Children With Lifelong Consumption of Fluoridated Water, JADA, 82, 354-358, (1971).

You should call your doctor for medical advice about serious adverse events. To report a serious adverse event or obtain product information, contact Cypress Pharmaceutical, Inc. at 1-800-793-2145 or FDA at 1-800-FDA-1088 (Toll Free).

Manufactured for: Cypress Pharmaceutical, Inc., Morristown, NJ 07960

P166 Rev. 6/2016

504433

PRINCIPAL DISPLAY PANEL - 56 g Tube Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

FRESH MINT
Rx ONLY
NDC 60258-151-01

SF 1.1% GEL

1.1% SODIUM FLUORIDE

Brush-on Gel (non-abrasive formula)

CYPRESS
PHARMACEUTICAL, INC.

NET WT. 2 OZ. (56 g)

PRINCIPAL DISPLAY PANEL - 56 g Tube CartonPRINCIPAL DISPLAY PANEL - 56 g Tube Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1486566sodium fluoride 1.1 % Oral GelPSN2
1486566sodium fluoride 0.011 MG/MG Oral GelSCD2
1486566sodium fluoride 1.1 % Oral GelSY2

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
60258-151-01SF56 g in 1 TUBEGEL562
60258-151-01SF1 in 1 CARTONGEL12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
60258-151SF (1.1% SODIUM FLUORIDE) GEL [CYPRESS PHARMACEUTICAL, INC.]2Current NDC, Legacy NDC, 2 package rows20160712_b7c0a768-7e8a-40b9-876f-b86d3dc5e848.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
60258-151-01GM - Gram60258-1519309d2e6-1c49-4c1d-97ec-a95a8105b08012014-04-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
SODIUM FLUORIDEACTIVE INGREDIENT8ZYQ1474W71
FLUORIDE IONACTIVE MOIETYQ80VPU408O1
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBD1
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)INACTIVE INGREDIENT8136Y38GY51
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9T1
POLOXAMER 407INACTIVE INGREDIENTTUF2IVW3M21
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OH1
SACCHARIN SODIUM DIHYDRATEINACTIVE INGREDIENTSB8ZUX40TY1
SORBITOLINACTIVE INGREDIENT506T60A25R1
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
60258-15160258-151-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHGEL / VAGINAL2 mgExact identifier — unii+dosage form
6 equally ranked IID candidates
POLOXAMER 407POLOXAMER 407TUF2IVW3M2GEL / TOPICAL28 mgExact identifier — unii+dosage form
6 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)8136Y38GY5SUSPENSION / ORAL1200 mgExact identifier — unii candidate
18 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)8136Y38GY5FILM / BUCCAL55 mgExact identifier — unii candidate
18 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDPASTE, DENTIFRICE / DENTALNAExact identifier — unii+route
6 equally ranked IID candidates
SACCHARIN SODIUM DIHYDRATESACCHARIN SODIUMSB8ZUX40TYGEL / DENTAL0.3 %w/wExact identifier — unii+route+dosage form
2 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHPASTE, DENTIFRICE / DENTALNAExact identifier — unii+route
6 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TGEL / TOPICAL24 mgExact identifier — unii+dosage form
6 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)8136Y38GY5TABLET, FILM COATED / ORAL1 mgExact identifier — unii candidate
18 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)8136Y38GY5TABLET, FILM COATED / ORAL1 mgExact identifier — unii candidate
18 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHPASTE, DENTIFRICE / DENTALNAExact identifier — unii+route
6 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)8136Y38GY5FILM, SOLUBLE / BUCCAL161 mgExact identifier — unii candidate
18 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)8136Y38GY5TABLET / ORAL2 mgExact identifier — unii candidate
18 equally ranked IID candidates
POLOXAMER 407POLOXAMER 407TUF2IVW3M2GEL / PERIODONTAL155 mgExact identifier — unii+dosage form
6 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RPASTE / DENTAL14.6 %w/wExact identifier — unii+route
4 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDPASTE / DENTALNAExact identifier — unii+route
6 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)8136Y38GY5CAPSULE / ORAL20 mgExact identifier — unii candidate
18 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDPASTE / DENTALNAExact identifier — unii+route
6 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TGEL / VAGINAL8 mgExact identifier — unii+dosage form
6 equally ranked IID candidates
POLOXAMER 407POLOXAMER 407TUF2IVW3M2GEL / OPHTHALMIC1 mgExact identifier — unii+dosage form
6 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDPASTE, DENTIFRICE / DENTALNAExact identifier — unii+route
6 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TGEL / TOPICAL24 mgExact identifier — unii+dosage form
6 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDSOLUTION / DENTALNAExact identifier — unii+route
6 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHGEL / TOPICAL4 mgExact identifier — unii+dosage form
6 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)8136Y38GY5FILM / BUCCAL55 mgExact identifier — unii candidate
18 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)8136Y38GY5TABLET, EXTENDED RELEASE / ORAL150 mgExact identifier — unii candidate
18 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)8136Y38GY5SOLUTION / ORAL1867 mgExact identifier — unii candidate
18 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)8136Y38GY5SYRUP / ORAL100 mg/5mlExact identifier — unii candidate
18 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RPASTE / DENTAL14.6 %w/wExact identifier — unii+route
4 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)8136Y38GY5SUSPENSION / ORAL1200 mgExact identifier — unii candidate
18 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHGEL / TOPICAL4 mgExact identifier — unii+dosage form
6 equally ranked IID candidates
SACCHARIN SODIUM DIHYDRATESACCHARIN SODIUMSB8ZUX40TYGEL / DENTAL0.3 %w/wExact identifier — unii+route+dosage form
2 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)8136Y38GY5TABLET, EXTENDED RELEASE / ORAL150 mgExact identifier — unii candidate
18 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)8136Y38GY5SYRUP / ORAL100 mg/5mlExact identifier — unii candidate
18 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)8136Y38GY5FILM, SOLUBLE / BUCCAL161 mgExact identifier — unii candidate
18 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TPASTE, DENTIFRICE / DENTAL0.05 %w/wExact identifier — unii+route
6 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RPASTE, DENTIFRICE / DENTAL14 %w/wExact identifier — unii+route
4 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TGEL / VAGINAL8 mgExact identifier — unii+dosage form
6 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RPASTE, DENTIFRICE / DENTAL14 %w/wExact identifier — unii+route
4 equally ranked IID candidates
POLOXAMER 407POLOXAMER 407TUF2IVW3M2GEL / OPHTHALMIC1 mgExact identifier — unii+dosage form
6 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)8136Y38GY5SOLUTION / ORAL1867 mgExact identifier — unii candidate
18 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHGEL / VAGINAL2 mgExact identifier — unii+dosage form
6 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TPASTE, DENTIFRICE / DENTAL0.05 %w/wExact identifier — unii+route
6 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDSOLUTION / DENTALNAExact identifier — unii+route
6 equally ranked IID candidates
POLOXAMER 407POLOXAMER 407TUF2IVW3M2GEL / TOPICAL28 mgExact identifier — unii+dosage form
6 equally ranked IID candidates
POLOXAMER 407POLOXAMER 407TUF2IVW3M2GEL / PERIODONTAL155 mgExact identifier — unii+dosage form
6 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)8136Y38GY5TABLET / ORAL2 mgExact identifier — unii candidate
18 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)8136Y38GY5CAPSULE / ORAL20 mgExact identifier — unii candidate
18 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SF1.1% SODIUM FLUORIDECypress Pharmaceutical, Inc.b7c0a768-7e8a-40b9-876f-b86d3dc5e8482016-07-06Warnings, Adverse reactionsExact identifier
ndc (package): 60258-151-01
ndc (product): 60258-151
ndc11 (package): 60258015101
spl id: 58792242-e746-40e6-b549-83cd5f2b7ac5
spl set id: b7c0a768-7e8a-40b9-876f-b86d3dc5e848

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.